CO5140091A1 - Derivados de piperidina y piperazina, su preparacion, su uso como productos farmaceuticos y composiciones farmaceuticas que los contienen - Google Patents

Derivados de piperidina y piperazina, su preparacion, su uso como productos farmaceuticos y composiciones farmaceuticas que los contienen

Info

Publication number
CO5140091A1
CO5140091A1 CO00006270A CO00006270A CO5140091A1 CO 5140091 A1 CO5140091 A1 CO 5140091A1 CO 00006270 A CO00006270 A CO 00006270A CO 00006270 A CO00006270 A CO 00006270A CO 5140091 A1 CO5140091 A1 CO 5140091A1
Authority
CO
Colombia
Prior art keywords
carbon atoms
jpeg
group
mfi
alkyl
Prior art date
Application number
CO00006270A
Other languages
English (en)
Inventor
Luond Rainer Martin
Markus Banziger
Peter Frey
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5140091A1 publication Critical patent/CO5140091A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/08—Aza-anthracenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/08—Diarylmethoxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se relaciona con un compuesto de la fórmula I:<EMI FILE="00006270_1" ID="1" IMF=JPEG >En donde:X es <EMI FILE="00006270_2" ID="2" IMF=JPEG > (a)Y R´ ´ es H u OH, y R´ es un grupo (b), (c), ó (d):<EMI FILE="00006270_3" ID="3" IMF=JPEG >o R´ ´ R´ ´ ´ cada uno son un grupo (c) ,en donde Z es H, halógeno, trifluorometilo, alquilo (de1 a 4 átomos de carbono), o alcoxilo (de 1 a 4 átomos decarbono), Qº es -0- , -NH-CO- o un enlace sencillo, y Rº de hidrógeno o hidroxilo,Y1 e Y2 es H, o, cuando X es <EMI FILE="00006270_4" ID="4" IMF=JPEG >en donde R´´ es H yR´ ´ ´ es un grupo (d), Y1 e Y2 pueden formar también juntos un puente de -CH2-CH2-, yR es un grupo (e) ó (f) :<EMI FILE="00006270_5" ID="5" IMF=JPEG >en donde:n es de 0 a 3,R1 es H alquilo (de 1 a 4 átomos de carbono) ,o -SO2-CH3, R2 es H, halógeno, alquilo (de 1 a 4 átomos de carbono), alcoxilo (de 1 a 4 átomos de carbono), tioalquilo (de 1 a 4 átomos de carbono) , o fenilo,R3 es H, alquilo (de 1 a 4 átomos de carbono) , o ungrupo (g) :<EMI FILE="00006270_6" ID="6" IMF=JPEG >en donde Z es como se define anteriormente,R4 y R5 cada uno son H, o forman juntos un enlace, o R4es H y R5 es alcoxilo (de 1 a 4 átomos de. carbono), R6 esalquilo (de 1 a 4 átomos de carbono), o un. grupo (g) yR7 es alcoxilo (de 1 a 4 átomos de carbono),en forma de base libre o de sal de adición de ácido.
CO00006270A 1999-02-10 2000-02-02 Derivados de piperidina y piperazina, su preparacion, su uso como productos farmaceuticos y composiciones farmaceuticas que los contienen CO5140091A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9902938.1A GB9902938D0 (en) 1999-02-10 1999-02-10 Organic compounds

Publications (1)

Publication Number Publication Date
CO5140091A1 true CO5140091A1 (es) 2002-03-22

Family

ID=10847440

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00006270A CO5140091A1 (es) 1999-02-10 2000-02-02 Derivados de piperidina y piperazina, su preparacion, su uso como productos farmaceuticos y composiciones farmaceuticas que los contienen

Country Status (20)

Country Link
US (1) US20020002170A1 (es)
EP (1) EP1150971A1 (es)
JP (1) JP2002536441A (es)
KR (1) KR20010102006A (es)
CN (1) CN1337960A (es)
AR (1) AR022542A1 (es)
AU (1) AU2803200A (es)
BR (1) BR0008068A (es)
CA (1) CA2362389A1 (es)
CO (1) CO5140091A1 (es)
CZ (1) CZ20012868A3 (es)
GB (1) GB9902938D0 (es)
HU (1) HUP0200133A3 (es)
ID (1) ID29283A (es)
IL (1) IL143779A0 (es)
NO (1) NO20013832L (es)
PE (1) PE20001460A1 (es)
SK (1) SK11372001A3 (es)
TR (1) TR200101924T2 (es)
WO (1) WO2000047571A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053127B1 (en) * 2002-09-16 2006-05-30 Nalco Company Quaternized amido cyclic amine surfactant
WO2004087159A1 (en) * 2003-03-26 2004-10-14 Merck & Co., Inc. Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
PL379466A1 (pl) * 2003-06-30 2006-09-18 Daiichi Sankyo Company , Limited Heterocykliczne pochodne metylosulfonu
CN106866657A (zh) * 2017-04-25 2017-06-20 成都倍特药业有限公司 一种麦角新碱的制备方法
US10729710B2 (en) 2017-11-24 2020-08-04 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's disease
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
GB9701628D0 (en) * 1997-01-27 1997-03-19 Pharmacia & Upjohn Spa Imino-aza-anthracyclinone derivatives

Also Published As

Publication number Publication date
AR022542A1 (es) 2002-09-04
KR20010102006A (ko) 2001-11-15
HUP0200133A2 (en) 2002-06-29
EP1150971A1 (en) 2001-11-07
PE20001460A1 (es) 2001-01-03
CZ20012868A3 (cs) 2001-10-17
NO20013832L (no) 2001-09-27
US20020002170A1 (en) 2002-01-03
AU2803200A (en) 2000-08-29
NO20013832D0 (no) 2001-08-06
ID29283A (id) 2001-08-16
SK11372001A3 (sk) 2001-12-03
IL143779A0 (en) 2002-04-21
WO2000047571A1 (en) 2000-08-17
JP2002536441A (ja) 2002-10-29
CN1337960A (zh) 2002-02-27
GB9902938D0 (en) 1999-03-31
BR0008068A (pt) 2001-11-13
TR200101924T2 (tr) 2002-01-21
HUP0200133A3 (en) 2003-01-28
CA2362389A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
CO5261501A1 (es) Derivados de acido pirazol-propionico y sus composiciones farmaceuticas
HUP0302962A2 (hu) Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
ES2221440T3 (es) Derivados de acido aminofenoxiacetico como neuroprotectores.
AR031597A1 (es) Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3
BR0014116A (pt) Uso de um composto, composto, métodos para preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
ATE152719T1 (de) Chinolylbenzofuran derivate als leukotrien- antagonisten
AR008545A1 (es) Compuestos substituidos de indano o de dihidroindol; composicion farmaceutica que los contiene y uso de dichos compuestos en la preparacionde un medicamento.
CO5170518A1 (es) Compuestos n-(benzocicloalquilo) derivados de amino aralifaticos
BR9806413A (pt) Composto e uso do mesmo
NZ331319A (en) Cyclic amine derivatives that are CCR-3 receptor (chemokine receptor) antagonists, compositions containing them and methods for their use (to combat eosinophil induced diseases).
HUP0302468A2 (hu) Alfa V integrin receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
CO5160290A1 (es) Derivados de acido fenoxifeniloxamico sustituido .
CO4820431A1 (es) Compuestos calciliticos habiles para inhibir la actividad receptora de calcio, composisicon farmaceutica y metodo de utilizacion
AR028531A1 (es) Compuestos organicos
AR045768A1 (es) Compuestos de cefem y sus sales farmaceuticamente aceptables
CO5140091A1 (es) Derivados de piperidina y piperazina, su preparacion, su uso como productos farmaceuticos y composiciones farmaceuticas que los contienen
CO4990932A1 (es) Derivados de 2,1,3-benzotiadiazol y proceso para su preparacion
AR033300A1 (es) Compuestos de cefem
AR002016A1 (es) Derivados de 3-fenilisoquinoleina-1-(2h)-ona, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen.
CO5140104A1 (es) Derivados de mevinolina y preparacion farmaceuticas que los contienen
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
BR0004823A (pt) Compostos policìclicos de azaindol, processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos
DE60020885D1 (de) Tetrahydropyridine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
AR018632A1 (es) Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion.
HUP0203383A2 (hu) Aminofenoxiacetamid-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények